Group 1 - The company, MicroTech Medical-B, recently repurchased 28,000 shares at an average price of HKD 7.75 per share, totaling approximately HKD 217,100, with a cumulative repurchase of 1,033,000 shares this year, representing 0.62% of the total share capital [1] - The stock price of MicroTech Medical-B increased by 3.72% to HKD 7.80 per share at the close of the Hong Kong stock market [1] - The repurchase activity is seen as a signal of management's confidence in the company's long-term value and aims to stabilize market sentiment amid volatility in the healthcare sector [1] Group 2 - MicroTech Medical-B is an innovative company focused on diabetes management and high-end medical device development, headquartered in Hangzhou, China [2] - The company's core products include patch insulin pump systems and continuous glucose monitoring systems, providing intelligent solutions for diabetes patients [2] - MicroTech Medical-B was listed on the Hong Kong Stock Exchange in October 2021 and has been expanding its global market presence through technological innovation [2] - The company has a significantly higher R&D investment ratio compared to the industry average, indicating strong technological drive [2] - As a leading player in the diabetes management sector in China, its products have received CE certification in the EU and approval from China's NMPA, with business operations covering multiple regions including Asia and Europe [2]